Apnimed Announces Three Oral Presentations and a Late-breaking Poster at the American Thoracic Society (ATS) 2026 International Conference

B CAMBRIDGE, Mass., May 11, 2026 /PRNewswire/ — Apnimed, Inc., a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral…
posteditor
posteditor
Articles: 21727

Other News